FR1380415A - Procédé de préparation de stéroïdes à double liaison en position 5 (10) - Google Patents

Procédé de préparation de stéroïdes à double liaison en position 5 (10)

Info

Publication number
FR1380415A
FR1380415A FR895563A FR895563A FR1380415A FR 1380415 A FR1380415 A FR 1380415A FR 895563 A FR895563 A FR 895563A FR 895563 A FR895563 A FR 895563A FR 1380415 A FR1380415 A FR 1380415A
Authority
FR
France
Prior art keywords
steroids
preparation
double bond
bond
double
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR895563A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR895563A priority Critical patent/FR1380415A/fr
Priority to FR905184A priority patent/FR2323M/fr
Priority to BR148576/63A priority patent/BR6348576D0/pt
Priority to CH504963A priority patent/CH414609A/fr
Priority to GB16057/63A priority patent/GB1015013A/en
Priority to DK189263AA priority patent/DK105336C/da
Priority to ES287334A priority patent/ES287334A1/es
Priority to AT336263A priority patent/AT253696B/de
Application granted granted Critical
Publication of FR1380415A publication Critical patent/FR1380415A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
FR895563A 1962-04-25 1962-04-25 Procédé de préparation de stéroïdes à double liaison en position 5 (10) Expired FR1380415A (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR895563A FR1380415A (fr) 1962-04-25 1962-04-25 Procédé de préparation de stéroïdes à double liaison en position 5 (10)
FR905184A FR2323M (fr) 1962-04-25 1962-07-26 Nouveau médicament notamment pour le traitement de l'hyperactivité folliculostimulante.
BR148576/63A BR6348576D0 (pt) 1962-04-25 1963-04-22 Processo de preparacao de esteroides com dupla ligacao na posicao 5(10)
CH504963A CH414609A (fr) 1962-04-25 1963-04-23 Procédé de préparation de stéroïdes à double liaison en position 5(10)
GB16057/63A GB1015013A (en) 1962-04-25 1963-04-23 Improvements in or relating to processes for the preparation of steroid compounds and the compounds thus prepared
DK189263AA DK105336C (da) 1962-04-25 1963-04-24 Fremgangsmåde til fremstilling af 3-oxo-17-hydroxy-13β-alkyl-Δ<5(10)>-gonener.
ES287334A ES287334A1 (es) 1962-04-25 1963-04-24 Un procedimiento de preparación de compuestos esteroides 5(10)-deshidro
AT336263A AT253696B (de) 1962-04-25 1963-04-25 Verfahren zur Herstellung von Steroiden mit einer Doppelbindung in der 5(10)-Stellung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR895563A FR1380415A (fr) 1962-04-25 1962-04-25 Procédé de préparation de stéroïdes à double liaison en position 5 (10)

Publications (1)

Publication Number Publication Date
FR1380415A true FR1380415A (fr) 1964-12-04

Family

ID=8777621

Family Applications (2)

Application Number Title Priority Date Filing Date
FR895563A Expired FR1380415A (fr) 1962-04-25 1962-04-25 Procédé de préparation de stéroïdes à double liaison en position 5 (10)
FR905184A Active FR2323M (fr) 1962-04-25 1962-07-26 Nouveau médicament notamment pour le traitement de l'hyperactivité folliculostimulante.

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR905184A Active FR2323M (fr) 1962-04-25 1962-07-26 Nouveau médicament notamment pour le traitement de l'hyperactivité folliculostimulante.

Country Status (7)

Country Link
AT (1) AT253696B (da)
BR (1) BR6348576D0 (da)
CH (1) CH414609A (da)
DK (1) DK105336C (da)
ES (1) ES287334A1 (da)
FR (2) FR1380415A (da)
GB (1) GB1015013A (da)

Also Published As

Publication number Publication date
BR6348576D0 (pt) 1973-07-03
CH414609A (fr) 1966-06-15
DK105336C (da) 1966-09-19
GB1015013A (en) 1965-12-31
ES287334A1 (es) 1963-07-16
FR2323M (fr) 1964-02-10
AT253696B (de) 1967-04-25

Similar Documents

Publication Publication Date Title
FR1380555A (fr) Procédé de préparation d&#39;iodure de perfluoroalcoyle
CH414608A (fr) Procédé de préparation d&#39;un nouveau stéroïde non saturé
FR1380415A (fr) Procédé de préparation de stéroïdes à double liaison en position 5 (10)
BE581426A (fr) Procédé de préparation d&#39;amino-stéroïdes
FR1462536A (fr) Procédé de préparation d&#39;alpha-indanones disubstituées en position bêta
CH426800A (fr) Procédé de préparation de stéroïdes hydroxy-hydroxy-méthylés
FR1371138A (fr) Procédé de préparation d&#39;hydroquinone
BE603719A (fr) Procédé de préparation de 4-sulfanilamido-quinazolines substituées en position 2
FR1313469A (fr) Procédé de préparation d&#39;alcoylidène bis-dibromophénols
FR1256388A (fr) Procédé de préparation d&#39;oléfines tertiaires
FR1341755A (fr) Procédé de préparation de stéroïdes apparentés à l&#39;oestradiol
CH451929A (fr) Procédé de préparation de l&#39;estrone
CH414634A (fr) Procédé de préparation d&#39;un dérivé du dibenzocyclophetadiène
CH405293A (fr) Procédé de préparation d&#39;un nouvel analogue éthynylé de l&#39;estradiol
FR1371626A (fr) Procédé de préparation de thioéthers de 1, 4-dihydroxyanthraquinonyle-2
FR1343644A (fr) Procédé de préparation de 1, 4-benzo-dioxannes
FR1341578A (fr) Procédé de préparation de 17 alpha-méthyl stéroïdes
FR1341601A (fr) Procédé de préparation de stéroïdes dioxygénés en 11, 19
FR1344649A (fr) Procédé de préparation d&#39;aminoanthraquinones bromées
CH413813A (fr) Procédé de préparation d&#39;a-acyloxy-propionaldéhydes
CH405301A (fr) Procédé de préparation de stéroïdes substitués en position 4
CH404653A (fr) Procédé de préparation d&#39;aminostéroïdes
FR1325510A (fr) Procédé de préparation de cyclodécène-(5) one-(1)
CH416616A (fr) Procédé de préparation d&#39;un nouveau stéroïde aminé
FR1437364A (fr) Procédé de préparation de cétostéroïdes apparentés à la 19-nortestostérone